Tekla Capital Management’s Insmed INSM Stock Holding History

Tekla Capital Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-98,387	Closed	-$2.8M	–	185
2021 Q2	$2.8M	Hold	98,387	–	–	0.09%	145
2021 Q1	$3.35M	Hold	98,387	–	–	0.12%	140
2020 Q4	$3.27M	Hold	98,387	–	–	0.12%	140
2020 Q3	$3.16M	Hold	98,387	–	–	0.12%	127
2020 Q2	$2.71M	Hold	98,387	–	–	0.1%	146
2020 Q1	$1.58M	Sell	98,387 -66,399	-40%	-$1.57M	0.07%	148
2019 Q4	$3.94M	Hold	164,786	–	–	0.15%	126
2019 Q3	$2.91M	Buy	+164,786	New	+$3.18M	0.13%	116
2016 Q2	–	Sell	-178,600	Closed	-$2.26M	–	160
2016 Q1	$2.26M	Buy	178,600 +22,000	+14%	+$289K	0.1%	115
2015 Q4	$2.84M	Buy	+156,600	New	+$2.76M	0.1%	108

Other funds holding INSM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Tekla Capital Management's INSM Position: Q3 2021 in Review

Tekla Capital Management sold out of Insmed (INSM) in Q3 2021, closing a stake of 98,387 shares — an estimated $2.8M sold.

Tekla Capital Management first reported a position in INSM in Q4 2015 and held it in 10 quarters. The position peaked at $3.94M in Q4 2019. 193 funds tracked by Wall St. Rank hold INSM as of Q3 2021.

Tekla Capital Management reported no remaining Insmed position as of Q3 2021 after selling out during the quarter.
Tekla Capital Management sold 98,387 Insmed shares in Q3 2021, an estimated $2.8M.
Tekla Capital Management first reported a position in Insmed in Q4 2015 and held it in 10 quarters.
Tekla Capital Management's Insmed position peaked at $3.94M in Q4 2019.
193 funds tracked by Wall St. Rank held Insmed as of Q3 2021.

Based on Tekla Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.